Jan Medical said today that it has launched a cooperative research and development deal with the US Army Medical Materiel Agency to evaluate its BrainPulse device. Jan Medical’s BrainPulse device is designed to non-invasively capture novel physiological signals through a patient’s cardiac output, used to measure vascular and brain tissue conditions, the company said. The data […]
Brainlab invests nearly $8m into Jan Medical
Jan Medical said today it obtained $7.5 million in Series C funding from partner Brainlab Inc, with funds slated to aid in completion of a clinical trial and filing for de novo clearance with the FDA and CE Mark approval in the European Union for its BrainPulse tool. Mountain View, Calif.-based Jan Medical’s BrainPulse device is designed to […]
Neurotech firms Jan Medical, Brainlab team up
Jan Medical is partnering with software-driven medtech firm Brainlab to gain FDA clearances via 2 clinical trials, the companies announced.
As part of the collaboration, Brainlab will add a representative to Jan Medical’s board, the companies said in a press release.
Mountain View, Calif.-based Jan Medical makes the the Nautilus NeuroWave, a portable, non-invasive brain sensing system designed to detect abnormal neurological conditions, including ischemic stroke, vasospasm, and concussion.
Mauna Kea looks to fetch $67 million from IPO
Mauna Kea Technologies is looking to raise up to $67 million through an initial public offering of 3.29 million shares on the NYSE Euronext stock exchange.
The offering will priced between 10.65 euros and 13 euros a share and is expected to close on July 4, according to Reuters news service .
